MétaCan
Menu
Back to cohort
Record W2039215773 · doi:10.3899/jrheum.120089

Access to Biologic Therapies in Canada for Children with Juvenile Idiopathic Arthritis

2012· article· en· W2039215773 on OpenAlexafffundvenueabout
Claire LeBlanc, Bianca Lang, ALMA BENCIVENGA, Anne-Laure Chetaille, Paul Dancey, Peter B. Dent, Päivi Miettunen, Kiem Oen, Alan Rosenberg, Johannes Roth, Rosie Scuccimarri, Shirley M. L. Tse, Susanne M. Benseler, David A. Cabral, Sarah Campillo, Gaëlle Chédeville, Ciarán M. Duffy, Karen Watanabe Duffy, Élie Haddad, Adam M. Huber, Ronald M. Laxer, Deborah M. Levy, Nicole Johnson, Suzanne Ramsey, Natalie J. Shiff, Heinrike Schmeling, Rayfel Schneider, Elizabeth Stringer, Rae S. M. Yeung, Lori B. Tucker

Bibliographic record

VenueThe Journal of Rheumatology · 2012
Typearticle
Languageen
FieldMedicine
TopicAutoimmune and Inflammatory Disorders Research
Canadian institutionsMcGill UniversityUniversity of OttawaMcMaster UniversityUniversité de MontréalUniversity of SaskatchewanUniversité LavalMontreal Children's HospitalUniversity of TorontoDalhousie UniversityUniversity of British ColumbiaUniversity of CalgaryUniversity of Manitoba
FundersNewfoundland and Labrador
KeywordsMedicineEtanerceptAbataceptFormularyReimbursementArthritisBiologic AgentsJuvenileFamily medicineJuvenile rheumatoid arthritisPediatricsHealth careInternal medicineDiseaseRheumatoid arthritisRituximab

Abstract

fetched live from OpenAlex

OBJECTIVE: To compare access to biologic therapies for children with juvenile idiopathic arthritis (JIA) across Canada, and to identify differences in provincial regulations and criteria for access. METHODS: Between June and August 2010, we compiled the provincial guidelines for reimbursement of biologic drugs for children with JIA and conducted a multicenter Canada-wide survey of pediatric rheumatologists to determine their experience with accessing biologic therapies for their patients. RESULTS: There were significant difficulties accessing biologic treatments other than etanercept and abatacept for children. There were large discrepancies in the access criteria and coverage of biologic agents across provinces, notably with age restrictions for younger children. CONCLUSION: Canadian children with JIA may not receive optimal internationally recognized "standard" care because pediatric coverage for biologic drugs through provincial formularies is limited and inconsistent across the country. There is urgent need for public policy to improve access to biologic therapies for these children to ensure optimal short-term and longterm health outcomes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.162
Threshold uncertainty score0.876

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.022
GPT teacher head0.285
Teacher spread0.263 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations31
Published2012
Admission routes4
Has abstractyes

Explore more

Same venueThe Journal of RheumatologySame topicAutoimmune and Inflammatory Disorders ResearchFrench-language works237,207